Inflammatory and oxidative stress markers in experimental crystalopathy: Their modification by photostimulation

Photomedicine and Laser Surgery

Volumn 27, Issue 1, 2009, Pages 79-84

  Rubio, Claudia Reinoso ^a   Simes, Juan Carlos ^a   Moya, Monica ^a,b   Soriano, Fernando ^c   Palma, Jose Atilio ^a   Campana, Vilma ^a,b,d  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de La Rioja   (Argentina)

^c Instituto Argentino de Medicina Láser   (Argentina)

^d NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM COMPOUNDS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; HYDROXYAPATITE; JOINTS (ANATOMY); NITRIC OXIDE;

ANTI-INFLAMMATORY EFFECTS; CALCIUM PYROPHOSPHATE; CELLULAR REACTIONS; LASER TREATED; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; OXIDATIVE STRESS MARKERS; PHOTO STIMULATIONS; PHOTOBIOSTIMULATION;

RATS;

EID: 61649122869     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2007.2232     Document Type: Article

References (32)

1. Choi, M.H., MacKenzie, J.D, and Dalinka, M.K. (2006). Imaging features of crystal-induced arthroapthy. Rheum. Dis. Clin. North Am. 32, 427-446.
2. Dalbeth, N., and Haskard, D.O. (2005). Inflammation and tissue damage in crystal deposition diseases. Curr. Opin. Rheumatol. 17, 314-318.
3. Wu, C.W., Terkeltaub, R., and Kalunian, K.C. (2005). Calcium-containing crystals and osteoarthritis: implications for the clinician. Curr. Rheumatol. Rep. 7, 213-219.
4. Wise, C.M. (2007). Crystal-associated arthritis in the elderly. Rheum. Dis. Clin. North Am. 33, 33-35.
5. Garcia, G.M., McCord, G.C., and Kumar, R. (2003). Hydroxyapatite crystal deposition disease. Semin. Musculoskelet. Radiol. 7, 187-193.
6. Agarwal, A. (2002). Clinical application of tests used in rheumatology. Indian J. Pediatr. 69, 889-892.
7. Chicu, M., and Badescu, M. (2005). Paraclinical methods for the assessment of chronic rheumatic inflammatory processes. Rev. Med. Chir. Soc. Med. Nat. Iasi. 109, 90-95.
8. Pham, T.N., Rahman, P., Tobin, Y.M., et al. (2003). Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. J. Rheumatol. 30, 2529-2534.
9. Marini, V., Babini, A., and Moretti, E. (2004). Determinación de citrulina y óxido nítrico en el suero de pacientes con artritis reumatoidea y otras enfermedades reumáticas. A.A.I.C. 35, 39-45.
10. Ciurtin, C., Cojocaru, V.M., and Miron, I.M. (2006). Correlation between different components of synovial fluid and pathogenesis of rheumatic diseases. Rom. J. Intern. Med. 44, 171-181.
11. Yudoh, K., van Trieu, N., Nakamura, H., et al. (2005). Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res. Ther. 7, 380-391.
12. Sandhu, J., Robertson, S., and Birnboim, H. (2003). Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 30, 1173-1181.
13. van der Harst, M., Bull, S., and Brama, P.A. (2006). Nitrite and nitrotyrosine concentrations in articular cartilage, subchondral bone, and trabecular bone of normal juvenile, normal adult, and osteoarthritic adult equine metacarpophalangeal joint. J. Rheumatol. 33, 1662-1667.
14. van den Berg, W.B. (2005). Animal models of arthritis. What have we learned? J. Rheumatol. 72, 7-9.
15. Crofford, L., Lipski, P.E., Brooks, P., et al. (2000). Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum. 43, 4-13.
16. Martinez Taboada, V.M., Blanco Alonso, R., Alonso Bartolomé, B., and Rodríguez Valverde, V. (2001). Artropatías microcristalinas II. Medicine. 8, 1773-1780, 18, 17.
17. Campana, V., Moya, M., Gavotto, A., et al. (1999). The relative effects of He-Ne laser and meloxicam on experimentally induced inflammation. Lasertherapy. 11, 36-43.
18. Campana, V., Moya, M., Gavotto, A., et al. (2003). He-Ne laser on microcrystalline arthropathies. J. Clin. Laser Med. Surg. 21, 99-103.
19. Campana, V., Moya, M., Gavotto, A., et al. (2004). Laser therapy on arthritis induced by urate crystals. Photomed. Laser Surg. 22, 499-503.
20. Gur, A., Cosut, A., Sarac, A.J., et al. (2003). Efficacy of different therapy regimes of low level laser in painful osteoarthritis of the knee: a double-blind and randomized-controlled study. Laser Surg. Med. 33, 330-338.
21. Mizutani, K., Musya, Y., and Wakae, K. (2004). A clinical study on serum prostaglandin E2 with LLLT. Photomed. Laser Surg. 22, 537-539.
22. Giuliani, A., Fernández, M., and Farinelli, M. (2004). Very low level laser therapy attenuates edema and pain in experimental models. Int. J. Tissue React. 26, 29-37.
23. Reddy, G. (2004). Photobiological basis and clinical role of low-intensity lasers in biology and medicine. J. Clin. Laser Med Surg. 22, 141-150.
24. Soriano, F., Campana, V., Moya, M., et al. (2006). Photomodulation of pain and inflammation on microcrystalline arthropathies: Experimental and clinical results. Photomed. Laser Surg. 24, 140-150.
25. Lubart, R., Eichler, M., Lavi, R., Friedman, H., and Shainger, A. (2005). Low-energy laser irradiation promotes cellular redox activity. Photomed. Laser Surg. 23, 3-9.
26. Karu, T., Pyatibrat, L., and Afanasyeva, N. (2005). Cellular effects of low power therapy can be mediated by nitric oxide. Lasers Surg Med. 36, 307-314.
27. Woolf, A.D., and Dieppe, P.A. (1987). Mediators of crystal-induced inflammation in the joint. Brit. Med. Bull. 43, 429-444.
28. Ratnoff, O.D., and Menzie, A.C. (1957). A new method for the determination of fibrinogen in small samples of plasma. J. Lab. Clin. Med. 37, 316-320.
29. Boyde, T.R., and Rahmatullah, M. (1980). Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal. Biochem. 107, 424-431.
30. Choi, J. (2003). Nitric production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin. Chim. Acta. 336, 83-87.
31. ter Steege, J.C., Koster-Kamphuis, L., van Straaten, E.A., Forget, P., and Burman, W.A. (1998). Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic. Biol. Med. 25, 953-963.
32. Scheines, E. (2004). Rehabilitación en Reumatología. Asociación de Reumatología de la Ciudad de Buenos Aires. Accessed at http://www.arcba.org.ar/notas-jul04/nota2.html